Kardiomiopati Dilatasi pada Pasien HIV-AIDS

Abstract

The heart and great vessels are not the sites most frequently affected by opportunistic infections and neoplastic processes in patients with acquired immune deficiency syndrome (AIDS). HIV-related disease is now recognized as an important cause of dilated cardiomyopathy, with a prevalence of 8%–30%. Patients with HIV-infection and dilated cardiomyopathy have a much worse prognosis than those with idiopathic dilated cardiomyopathy. Cardiac involvement in HIV represents a pathophysiologic, diagnostic and therapeutic challenge for cardiologists. This review describes pathophysiology, diagnosis, treatment and prognosis of HIV- dilated cardiomyopathy.